Patents by Inventor Paolo Di Francesco

Paolo Di Francesco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of infections with alpha thymosin peptides
    Patent number: 8389680
    Abstract: A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The method is particularly useful in preventing an infection by Aspergillus in an immuno-compromised host being treated with a bone marrow transplantation.
    Type: Grant
    Filed: May 29, 2012
    Date of Patent: March 5, 2013
    Assignee: SciClone Pharmaceuticals, Inc.
    Inventors: Guido Rasi, Enrico Garaci, Francesco Bistoni, Luigina Romani, Paolo Di Francesco
  • TREATMENT OF ASPERGILLUS INFECTIONS WITH ALPHA THYMOSIN PEPTIDES
    Publication number: 20120295840
    Abstract: A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The method is particularly useful in preventing an infection by Aspergillus in an immuno-compromised host being treated with a bone marrow transplantation.
    Type: Application
    Filed: May 29, 2012
    Publication date: November 22, 2012
    Applicant: SCICLONE PHARMACEUTICALS, INC.
    Inventors: Guido RASI, Enrico GARACI, Francesco BISTONI, Luigina ROMANI, Paolo Di Francesco
  • Treatment of infections with alpha thymosin peptides
    Patent number: 8207294
    Abstract: A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The method is particularly useful in preventing an infection by Aspergillus in an immuno-compromised host being treated with a bone marrow transplantation.
    Type: Grant
    Filed: March 29, 2004
    Date of Patent: June 26, 2012
    Assignee: SciClone Pharmaceuticals, Inc.
    Inventors: Guido Rasi, Enrico Garaci, Francesco Bistoni, Luigina Romani, Paolo Di Francesco
  • Treatment of aspergillus infections with alpha thymosin peptides
    Publication number: 20070129292
    Abstract: A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The method is particularly useful in preventing an infection by Aspergillus in an immuno-compromised host being treated with a bone marrow transplantation.
    Type: Application
    Filed: March 29, 2004
    Publication date: June 7, 2007
    Applicant: SciClone Pharmaceuticals, Inc.
    Inventors: Guido Rasi, Enrico Garaci, Francesco Bistoni, Luigina Romani, Paolo Di Francesco